SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16 of the
Securities Exchange Act of 1934
For the month of July 2022
Commission file number: 001-32749
FRESENIUS MEDICAL CARE AG & Co. KGaA
(Translation of registrant's name into English)
Else-Kröner Strasse 1
61346 Bad Homburg
Germany
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F x Form 40-F ¨
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨
EXHIBITS
The following exhibits are being furnished with this Report:
Exhibit 99.1 | Ad-hoc release issued on July 27, 2022. |
Exhibit 99.2 | Press Release issued on July 27, 2022. |
The disclaimer included in Exhibit 99.2 is an integral part of this report, including the exhibits furnished herewith.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
DATE: July 28, 2022
Fresenius Medical Care AG & Co. KGaA, | |||
a partnership limited by shares, represented by: | |||
fresenius medical care management ag, | |||
its General Partner | |||
By: | /s/ Rice Powell | ||
Name: | Rice Powell | ||
Title: | Chief Executive Officer and | ||
Chairman of the Management Board of the General Partner |
By: | /s/ Helen Giza | ||
Name: | Helen Giza | ||
Title: | Deputy Chief Executive Officer, Chief Financial Officer and | ||
Member of the Management Board of the General Partner |